Elymus repens pollen

DB10489ApprovedAllergenicsNon-Standardized Pollen Allergenic Extract

Elymus repens pollen is an extract from Elymus repens pollen used in allergy testing.

First approval
United States, 1965
Also known as
quackgrass pollen extract

Resolves to

Compound
UNIION2T85TA2O
Clinical / RWD
RxNorm852343

What you can answer from here — as of April 02, 2025

64Drug interactionsStructured to mechanism, not free text
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
29Marketed productsAcross 1 country and 6 labellers
Sign in

Which other approved drugs treat the same conditions as Elymus repens pollen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In